YKYosuke Kumamoto

Yosuke Kumamoto

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yosuke Kumamoto has a total of 109 co-authors. Here are the top co-authors by number of shared publications:

  • Akiko Iwasaki

    Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA

    7 shared publications
  • Naoya Tatsumi

    Center for Immunity and Inflammation Rutgers New Jersey Medical School Newark New Jersey USA

    4 shared publications
  • Nobuaki Higashi

    Laboratory of Cancer Biology and Molecular Immunology, Graduate School of Pharmaceutical Sciences, the University of Tokyo, Tokyo, Japan

    4 shared publications
  • Akiko Iwasaki

    Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA; Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, USA

    3 shared publications
  • Kaori Denda-Nagai

    Laboratory of Cancer Biology and Molecular Immunology, Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan

    3 shared publications
  • Naoya Tatsumi

    Center for Immunity and Inflammation, Rutgers New Jersey Medical School, Newark, USA

    3 shared publications

Latest Publications

  • Open Access

    Distinct migratory dendritic cell subsets cooperate to prime tissue-resident memory-like CD8⁺ T cells in mouse tumors

    by Nathan Vaudiau, Pierre Bourdely, Maria Semitekolou, Agathe Ok, Louise Gorline, Aboubacar Sidiki K. Coulibaly, Matthieu Rastello, Aurélie Semervil, Roberto Savoldelli, Yohan Gerber-Ferder, et al.

    Tumor-infiltrating tissue-resident memory (TRM)-like CD8+ T cells correlate with positive prognosis and better responses to cancer immunotherapy, yet the mechanisms underlying their specification remain ill-understood. Here, we use the KP (KrasG12D, p53-/-) mouse model of lung adenocarcinoma to investigate how different dendritic cell (DC) subsets shape tumor-specific CD8+ T cell responses. Selective ablation of XCR1+ DC1s or IRF4-dependent CD11b+ DC2s reveal that DC1s, but not DC2s, are required for the generation of tumor-infiltrating effector and exhausted CD8+ T cells. By contrast, both migratory DC1s and migratory DC2s contribute to the specification of CD103+CD69+ TRM-like CD8+ T cells in tumor-draining lymph nodes. Mechanistically, low peptide/MHC-I density on migratory DC2s favors TGFβ-dependent TRM differentiation, while high peptide/MHC-I density on DC1s promote proliferative expansion of TRM-like cells; in addition, IL-12 secreted by DC1s enhances CXCR6 expression. Together, our findings uncover complementary functions of migratory DC subsets in shaping anti-tumor TRM-like CD8+ T cell responses, and also implicate targeting multiple DC subsets for optimizing cancer immunotherapy.


  • Open Access

    XCR1+ and CD11b+ migratory dendritic cells cooperate for the cross-priming of intratumoral CD8+ T cells with a tissue-resident memory phenotype.

    by Pierre Guermonprez, Nathan Vaudiau, Pierre Bourdely, Agathe Ok, Maria Semitekolou, Louise Gorline, Roberto Savoldelli, Yohan Gerber-Ferder, Fillipe Do Carmo, Aurélie Sémervil, et al.

    The composition and diversity of tumor-infiltrating CD8+ T cell populations have important consequences on the development of anti-tumor immunity. In a murine model of lung cancer, we have addressed the role of dendritic cell subsets on the generation of various types of tumor-infiltrating CD8+ T cells. We show that CD44+PD1- effector and PD1+TIM3+ exhausted, tumor-infiltrating CD8+ T cells require XCR1+ DC1s but not IRF4-dependent CD11b+ DC2s. By contrast, immunotherapy responsive CD103+CXCR6+ TRM-like, tumor-infiltrating CD8+ T cells require both DC1s and DC2s. The same requirement is found in tumor-draining lymph nodes where we identify CD103+CXCR6+ TRM-like precursors that are dependent on both XCR1+ DC1s and CD11b+, migratory DC2s. Mechanistically, we evidence that both types of migratory DCs cooperate. Mild TCR triggering by low MHCI-peptide density at the surface of cross-presenting migratory DC2s and low IL-12 support TGF-β -dependent TRM specification in lymph nodes. High TCR triggering and high MHCI-peptide density at the surface of cross-presenting migratory DC1s and high IL-12 support proliferative expansion and CXCR6 acquisition. Altogether, these findings highlight the induction of intratumoral TRM-like cells under the collective aegis of multiple DCs subsets within tumor-draining lymph nodes reconciliating TRM phenotype instruction with proliferative expansion.

  • Open Access

    Functional Specialization and Collaboration of cDC2 Subsets in CD4 + T Cell Priming and Differentiation

    by Naoya Tatsumi, Ariel Tjitropranoto, Alejandro Davila‐Pagan, Yosuke Kumamoto

    Dendritic cells (DCs) play a crucial role in bridging innate and adaptive immunity by presenting antigens to prime antigen‐specific T cells. Conventional DC (cDC) type 2 cells (cDC2s) are a phenotypically heterogeneous population of DCs highly capable of presenting antigens to CD4+ T cells. Studies found functional differences between different cDC2 subsets in regulating effector CD4+ T helper (Th) cells, but collaboration between different cDC subsets has also been suggested. In this review, we discuss recent advances in understanding the subset‐specific role of cDC2s in regulating Th cells.


  • Open Access

    The role of IL-2 in type 2 immunity

    by Naoya Tatsumi, Yosuke Kumamoto

    Type 2 immune responses are essential for protective immunity against helminth parasites and for promoting tissue repair, but they can also drive allergic inflammation. T helper type 2 (Th2) cells and group 2 innate lymphoid cells (ILC2s) are key drivers of these responses, producing hallmark type 2 cytokines such as IL-4, IL-5, IL-9 and/or IL-13. While IL-2 has long been recognized as a T cell growth factor, emerging evidence reveals its central role in shaping Th2 cell fate and function. This review focuses on recent studies on how the availability of IL-2 is regulated in vivo for inducing Th2 cells. We also discuss the role of IL-2 in activating ILC2s and thereby linking innate and adaptive immune system in the context of type 2 immunity. Together, the studies discussed here highlight the role of IL-2 as a spatially and functionally dynamic coordinator of type 2 immunity.


  • Open Access

    CD301b+ dendritic cell-derived IL-2 dictates CD4+ T helper cell differentiation

    by Naoya Tatsumi, Jihad El-Fenej, Alejandro Davila-Pagan, Yosuke Kumamoto

    T helper (Th) cell differentiation is fundamental to functional adaptive immunity. Different subsets of dendritic cells (DC) preferentially induce different types of Th cells, but the DC-derived mechanism for Th type 2 (Th2) differentiation is not fully understood. Here, we show that in mice, CD301b+ DCs, a major Th2-inducing DC subset, drive Th2 differentiation through cognate interaction by rapidly inducing IL-2 receptor signalling in CD4+ T cells. Mechanistically, CD40 engagement prompts IL-2 production selectively from CD301b+ DCs to maximize CD25 expression in CD4+ T cells, which instructs the Th2 fate decision, while simultaneously skewing CD4+ T cells away from the T follicular helper fate. Moreover, CD301b+ DCs utilize their own CD25 to facilitate directed action of IL-2 toward cognate CD4+ T cells, as genetic deletion of CD25 in CD301b+ DCs results in reduced IL-2-mediated signalling in antigen-specific CD4+ T cells and hence their Th2 differentiation. These results highlight the critical role of DC-intrinsic CD40–IL-2 axis in Th cell fate decision.


  • Open Access

    Rapid activation of IL-2 receptor signaling by CD301b + DC-derived IL-2 dictates the outcome of helper T cell differentiation

    by Naoya Tatsumi, Jihad El-Fenej, Alejandro Davila-Pagan, Yosuke Kumamoto

    Effector T helper (Th) cell differentiation is fundamental to functional adaptive immunity. Different subsets of dendritic cells (DCs) preferentially induce different types of Th cells, but the fate instruction mechanism for Th type 2 (Th2) differentiation remains enigmatic, as the critical DC-derived cue has not been clearly identified. Here, we show that CD301b + DCs, a major Th2-inducing DC subset, drive Th2 differentiation through cognate interaction by ‘kick-starting’ IL-2 receptor signaling in CD4T cells. Mechanistically, CD40 engagement induces IL-2 production selectively from CD301b + DCs to maximize CD25 expression in CD4 T cells, which is required specifically for the Th2 fate decision. On the other hand, CD25 in CD301b + DCs facilitates directed action of IL-2 toward cognate CD4T cells. Furthermore, CD301b + DC-derived IL-2 skews CD4T cells away from the T follicular helper fate. These results highlight the critical role of DC-intrinsic CD40–IL-2 axis in bifurcation of Th cell fate.


  • Effective CD4 T cell priming requires repertoire scanning by CD301b + migratory cDC2 cells upon lymph node entry

    by Naoya Tatsumi, Alicia L. Codrington, Jihad El-Fenej, Varoon Phondge, Yosuke Kumamoto

    CD301b + migratory cDC2 cells temporarily retain polyclonal CD4 T cells during priming to scan their antigen specificity.


  • Open Access

    Optimal CD4T Cell Priming in Lymph Nodes Requires Repertoire Scanning by CD301b + Migratory cDC2 Cells

    by Naoya Tatsumi, Alicia L Codrington, Yosuke Kumamoto

    Summary: Activation of CD4T cells by conventional dendritic cells (cDC) is pivotal in adaptive immunity. However, while the activation mechanism of antigen-specific CD4T cells has been extensively studied, the cellular mechanism that leads to the selection of cognate CD4T cell clones out of the polyclonal pool is incompletely understood. Here, we show that, in the reactive lymph nodes, newly homed naive polyclonal CD4T cells are temporarily retained before leaving the lymph node. This stop-and-go traffic of CD4T cells provides an adequate time window for efficient scanning and timely priming of antigen-specific clones. Mechanistically, upon immunization, CD301b + DCs, a major subset of migratory cDC2 cells, quickly migrate to the draining lymph node and settle in the areas near the high endothelial venules, where they retain incoming polyclonal CD4T cells through MHCII-dependent but antigen-independent mechanisms while concurrently providing cognate stimuli to prime antigen-specific CD4T cells. These results indicate that CD301b + DCs function as an immunological “display window” for CD4T cells to efficiently scan their antigen specificity. Graphical Highlights: Newly homed polyclonal CD4T cells are temporarily retained in the reactive lymph nodes. Depletion of CD301b + DCs results in shorter dwell time of CD4T cells in the draining lymph node and delayed priming of antigen-specific clones. The transient retention of polyclonal CD4T cells in the draining lymph node requires MHCII expression on CD301b + DCs but not cognate antigen. CD301b + DCs are required for robust expansion of rare antigen-specific CD4T cell clones and their skewing toward Th2 cells.